PVA-PEG physically cross-linked hydrogel film as a wound dressing: Experimental design and optimization
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - year:2017 |
---|---|
Enthalten in: |
Pharmaceutical development and technology - (2017), Seite 1-25 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ahmed, Afnan Sh [VerfasserIn] |
---|
Links: |
---|
BKL: |
---|
doi: |
10.1080/10837450.2017.1295067 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC1991426763 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1991426763 | ||
003 | DE-627 | ||
005 | 20230715034629.0 | ||
007 | tu | ||
008 | 170303s2017 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1080/10837450.2017.1295067 |2 doi | |
028 | 5 | 2 | |a PQ20170721 |
035 | |a (DE-627)OLC1991426763 | ||
035 | |a (DE-599)GBVOLC1991426763 | ||
035 | |a (PRQ)crossref_primary_10_1080_10837450_2017_12950670 | ||
035 | |a (KEY)0294643220170000000000000001pvapegphysicallycrosslinkedhydrogelfilmasawounddre | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DE-600 |
084 | |a PHARM |2 fid | ||
084 | |a 44.40 |2 bkl | ||
100 | 1 | |a Ahmed, Afnan Sh |e verfasserin |4 aut | |
245 | 1 | 0 | |a PVA-PEG physically cross-linked hydrogel film as a wound dressing: Experimental design and optimization |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
700 | 1 | |a Mandal, Uttam Kumar |4 oth | |
700 | 1 | |a Taher, Muhammad |4 oth | |
700 | 1 | |a Susanti, Deny |4 oth | |
700 | 1 | |a Jaffri, Juliana Md |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Pharmaceutical development and technology |d Philadelphia, Pa. : Informa Healthcare, 1996 |g (2017), Seite 1-25 |w (DE-627)214124622 |w (DE-600)1331774-X |w (DE-576)435516191 |x 1083-7450 |7 nnns |
773 | 1 | 8 | |g year:2017 |g pages:1-25 |
856 | 4 | 1 | |u http://dx.doi.org/10.1080/10837450.2017.1295067 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a SSG-OPC-PHA | ||
936 | b | k | |a 44.40 |q AVZ |
951 | |a AR | ||
952 | |j 2017 |h 1-25 |